Your session is about to expire
← Back to Search
Mindfulness-Based Therapy for Insomnia with Cognitive-Behavioral Symptom Coping Skills for Blood Cancers
Study Summary
This trial is studying a new approach to treating insomnia for patients with hematologic cancer who frequently report significant difficulties with sleep. The new approach is called Mindfulness-Based Therapy for Insomnia (MBTI) and it is a group-based intervention that combines sleep restriction and stimulus control with mindfulness principles and exercises to reduce worry and promote positive responses to insomnia. The study will be conducted in two phases. In Phase I, the study team will use focus groups with hematologic cancer patients and hematology-oncology providers to guide development along with user testing with hematologic cancer patients reporting insomnia and daytime symptoms of fatigue, pain,
- Blood Cancers
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current enrolment of this clinical trial?
"Affirmative. Clinicaltrials.gov data is indicative of the fact that this medical investigation, which was first announced on April 1st 2021, is presently searching for research participants. The study requires 53 individuals to be recruited from one specific site."
Are there any open opportunities to participate in this experiment?
"Confirmatively, data hosted on clinicaltrials.gov reveals that this medical research endeavour is presently recruiting participants. The trial was initially posted on April 1st 2021 and was recently revised as of January 27th 2022 with the aim to recruit 53 patients from a single site."
What therapeutic goals is this trial attempting to accomplish?
"For the purpose of this 12-week trial, primary evaluation will be centered on feasibility as suggested by study attrition. Additional outcomes include modifications in anxiety and depression (HADS), mindfulness skills (KIMS) and self-efficacy for symptom management (SECDS)."
Share this study with friends
Copy Link
Messenger